Member-only story
In a world where our attention spans often dwindle under the constant deluge of notifications and endless screen time, Akili Interactive has taken a bold step to reverse this trend. Their mobile game, Endeavor, emerged as a unique solution, gaining approval from the US Food and Drug Administration (FDA) in 2020 as a bona fide treatment for ADHD in children. And now, there’s exciting news — the FDA has expanded its endorsement to include older kids and teens up to the age of 17, making this groundbreaking video game accessible to all youngsters aged 8 and above. Plus, there’s even an off-label version designed specifically for adults.
But the crucial question remains — does it work? This is a query that adults are pondering as they explore the potential of Endeavor and evaluate not only its therapeutic effectiveness but also its entertainment value. It’s akin to a digital prescription with a twist.
In a world where many still struggle to find suitable ADHD treatments, Endeavor provides a glimmer of hope, especially as the US grapples with a post-pandemic drug shortage, further exacerbated by the surging demand for stimulants like Adderall. For those seeking alternatives or supplementary activities to sharpen their focus and attention, embracing a video game might just be the next logical step.
